The Press

Fisher & Paykel Health­care profit up 86pc

- Business · Health · Medicine · Health Care · Infectious Diseases · Therapy · Medical Treatments · Health Conditions · Fisher & Paykel Ltd. · Fisher & Paykel Healthcare

Fisher & Paykel Health­care, which has ben­e­fited from a surge in de­mand for its breath­ing aids dur­ing the coro­n­avirus pan­demic, posted an 86 per cent jump in first-half profit and lifted its fore­cast for the full year. Af­ter-tax profit rose to $225.5mil­lion in the six months to Septem­ber 30, from $121.2m last year. Rev­enue in­creased 59 per cent to $910.2m. Fisher & Paykel Health­care has ex­pe­ri­enced un­prece­dented de­mand for its breath­ing de­vices this year as hos­pi­tals stocked up on the ma­chines and ac­ces­sories used to help treat pa­tients with the coro­n­avirus. Dur­ing the half year, de­mand for its hos­pi­tal hard­ware in­creased, as clin­i­cians in­creas­ingly used nasal high flow ther­apy as a front­line treat­ment for Covid-19 pa­tients.

Newspapers in English

Newspapers from New Zealand